MAGEA1 and ovarian carcinoma: Coincidentally, Hofmann et al.42found that testing for BAGE, GAGE‐1/2, MAGE‐1, and MAGE‐3 mRNAs in ascites specimens of ovarian cancer patients results in high sensitivity in diagnosing malignant ascites.